Search Within

Breast Medicine Service

Formats
  1. Journal Article (2206)
  2. Meeting Abstract (1680)
  3. Review (83)
  4. Book Section (69)
  5. Editorial (44)
  6. Conference Paper (28)
  7. Guidelines (27)
  8. Correspondence (16)
  9. Miscellaneous (12)
  10. Research Letter (11)
  11. Book Whole (5)
Groups
  1. Department of Medicine (4181)
  2. Solid Tumor Oncology Division (4181)
  3. Survivorship Research (2373)
  4. GSK Faculty (1516)
  5. Population Sciences Research Program (1369)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1144)

More Groups

People
  1. Clifford Hudis (906)
  2. Larry Norton (762)
  3. Mark Robson (684)
  4. Neal Rosen (427)
  5. Andrew Seidman (319)
  6. Kenneth Offit (300)

More People

Years
  1. 2025 (130)
  2. 2024 (195)
  3. 2023 (168)
  4. 2022 (219)
  5. 2021 (236)
  6. 2020 (250)

More Years

Publications
  1. Journal of Clinical Oncology (828)
  2. Cancer Research (481)
  3. Breast Cancer Research and Treatment (170)
  4. Annals of Oncology (159)
  5. Clinical Cancer Research (132)
  6. Cancer (78)

More Publications

Publishers
  1. American Society of Clinical Oncology (880)
  2. American Association for Cancer Research (755)
  3. Springer (332)
  4. Elsevier Inc. (308)
  5. Oxford University Press (282)
  6. Nature Publishing Group (276)

More Publishers

Results (4181)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Should adjuvant weekly paclitaxel be considered less efficacious than anthracyclines plus cyclophosphamide for lower-risk patients with early-stage breast cancer? - Reply
    Journal Article

    Shulman, L. N.; Berry, D. A.; Cirrincione, C. T.; Hudis, C. A.; Winer, E. P.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Obesity and cancer: Local and systemic mechanisms
    Journal Article

    Iyengar, N. M.; Hudis, C. A.; Dannenberg, A. J.
    Annual Review of Medicine (2015)

    Fulltext@MSK | Save
  • Prospective blinded study of BRAFV600E mutation detection in cell-free DNA of patients with systemic histiocytic disorders
    Journal Article

    Hyman, D. M.; Diamond, E. L.; Vibat, C. R. T.; Hassaine, L.; Poole, J. C.; Patel, M.; Holley, V. R.; Cabrilo, G.; Lu, T. T.; Arcila, M. E.; more...
    Cancer Discovery (2015)

    Fulltext@MSK | Save
  • Phase II study of paclitaxel given once per week along with trastuzumab and pertuzumab in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer
    Journal Article

    Dang, C.; Iyengar, N.; Datko, F.; D'Andrea, G.; Theodoulou, M.; Dickler, M.; Goldfarb, S.; Lake, D.; Fasano, J.; Fornier, M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • The Rho GTPase Rnd1 suppresses mammary tumorigenesis and EMT by restraining Ras-MAPK signalling
    Journal Article

    Okada, T.; Sinha, S.; Esposito, I.; Schiavon, G.; Lopez Lago, M. A.; Su, W. J.; Pratilas, C. A.; Abele, C.; Hernandez, J. M.; Ohara, M.; more...
    Nature Cell Biology (2015)

    Fulltext@MSK | Save
  • Surgical patterns of care in patients with invasive breast cancer treated with neoadjuvant systemic therapy and breast magnetic resonance imaging: Results of a secondary analysis of TBCRC 017
    Journal Article

    McGuire, K. P.; Hwang, E. S.; Cantor, A.; Golshan, M.; Meric-Bernstam, F.; Horton, J. K.; Nanda, R.; Amos, K. D.; Forero, A.; Hudis, C. A.; more...
    Annals of Surgical Oncology (2015)

    Fulltext@MSK | Save
  • Adjuvant therapy-related shortening of survival (ATRESS): An underrated phenomenon - Authors reply
    Journal Article

    Xu, B.; Seidman, A.; Chan, S.
    The Oncologist (2015)

    Fulltext@MSK | Save
  • Serum metabolomic profiles evaluated after surgery may identify patients with oestrogen receptor negative early breast cancer at increased risk of disease recurrence. Results from a retrospective study
    Journal Article

    Tenori, L.; Oakman, C.; Morris, P. G.; Gralka, E.; Turner, N.; Cappadona, S.; Fornier, M.; Hudis, C.; Norton, L.; Luchinat, C.; more...
    Molecular Oncology (2015)

    Fulltext@MSK | Save
  • Impact of the addition of carboplatin and/or bevacizumab to neoadjuvant once-per-week paclitaxel followed by dose-dense doxorubicin and cyclophosphamide on pathologic complete response rates in stage II to III triple-negative breast cancer: CALGB 40603 (Alliance)
    Journal Article

    Sikov, W. M.; Berry, D. A.; Perou, C. M.; Singh, B.; Cirrincione, C. T.; Tolaney, S. M.; Kuzma, C. S.; Pluard, T. J.; Somlo, G.; Port, E. R.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Candidate genetic modifiers for breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers
    Journal Article

    Peterlongo, P.; Chang-Claude, J.; Boysich, K. B.; Rudolph, A.; Schmutzler, R. K.; Simard, J.; Soucy, P.; Eeles, R. A.; Easton, D. F.; Hamann, U.; more...
    Cancer Epidemiology Biomarkers and Prevention (2015)

    Fulltext@MSK | Save